Review





Similar Products

96
Innovative Research Inc pooled human plasma
Pooled Human Plasma, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+plasma/Pooled+Human+Plasma/pmc13760191-862-15-18
Average 96 stars, based on 1 article reviews
pooled human plasma - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
Monobind frozen human plasma
Frozen Human Plasma, supplied by Monobind, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+plasma/Human+Plasma+-+Recovered+Units/10__1021_slash_acscatal__6c02903-61-57-61
Average 94 stars, based on 1 article reviews
frozen human plasma - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
R&D Systems plasma levels
(A) Mass spectrometry-based proteomics of LEVs from BAV (n=12) and TAV (n=8). (A) Venn diagram of quantified proteins and the proportion of proteins previously identified in LEVs from platelets, endothelial cells, neutrophils, erythrocytes, and lipoproteins. [*] indicates that some proteins were identified in multiple data sets. Proteome overlap analysis (Supplementary Table 4). (B) Gene Ontology (GO) Cellular Component enrichment analysis of all quantified LEV proteins. All Cellular Component pathways and annotations (Supplementary Table 5). (C) Plasma LEV principal component analysis with density plots. (D) Venn diagram of the proteins unique to TAV (n=18) or BAV (n=93) or shared between the groups (n=804). Full list of unique proteins (Supplementary Table 6). (D) Volcano plot of differentially enrichment analysis between BAV and TAV using a t-test. Proteins highlighted in red are enriched in TAV (n=5), proteins highlighted in blue and enriched in BAV (n=98, p<0.05, Supplementary Table 8). (F) Orthogonal validation of differentially enriched proteins by immunoblotting and densitometric quantification of osteopontin (SPP1), thrombospondin 4 (THBS4), CD62P (SELP) and Emilin 1. Statistical significance of the relative signal intensity normalized to total protein (unmodified membranes, Supplementary Figure 5) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating the interquartile range (IQR), the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=7 per group). (G) Unsupervised hierarchical clustering of the differentially enriched proteins (p<0.05). (H) Reactome pathway enrichment analysis of proteins enriched (n=5) or uniquely quantified (n=18) in TAV. All Reactome pathways and annotations (Supplementary Table 9). (I) GO Cellular Component enrichment analysis of proteins enriched (n=98) in BAV. All GO Cellular Component pathways and annotations (Supplementary Table 10). (J) Orthogonal validation of differential abundance of “Ficolin-1 rich Granule” and “Tertiary Granule” associated proteins cathepsin D (CTSD) and CD58 as well as <t>classic</t> <t>neutrophil</t> degranulation markers neutrophil elastase (ELANE), myeloperoxidase <t>(MPO),</t> and Ficolin-1 (FCN1) by immunoblotting and densitometric quantification of relative signal intensities normalized to total protein (unmodified membranes, Supplementary Figure 6) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating IQR, the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=6 per group). (K) Functional Network of BAV-associated proteins. Network based on Reactome pathway enrichment among proteins significantly differentially enriched (n=98) or unique (n=93) in BAV. Protein-protein interaction network was produced by mapping the gene list onto STRING (confidence level >0.700) and k-means clustering partitioned the network into distinct functional modules.
Plasma Levels, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+plasma/Human+Myeloperoxidase+Quantikine+ELISA+Kit/bio_rxiv__64898__2026__11__03__763956-68-4-18
Average 95 stars, based on 1 article reviews
plasma levels - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Shanghai Korain Biotech Co Ltd plasma cyp2c19 protein levels
(A) Mass spectrometry-based proteomics of LEVs from BAV (n=12) and TAV (n=8). (A) Venn diagram of quantified proteins and the proportion of proteins previously identified in LEVs from platelets, endothelial cells, neutrophils, erythrocytes, and lipoproteins. [*] indicates that some proteins were identified in multiple data sets. Proteome overlap analysis (Supplementary Table 4). (B) Gene Ontology (GO) Cellular Component enrichment analysis of all quantified LEV proteins. All Cellular Component pathways and annotations (Supplementary Table 5). (C) Plasma LEV principal component analysis with density plots. (D) Venn diagram of the proteins unique to TAV (n=18) or BAV (n=93) or shared between the groups (n=804). Full list of unique proteins (Supplementary Table 6). (D) Volcano plot of differentially enrichment analysis between BAV and TAV using a t-test. Proteins highlighted in red are enriched in TAV (n=5), proteins highlighted in blue and enriched in BAV (n=98, p<0.05, Supplementary Table 8). (F) Orthogonal validation of differentially enriched proteins by immunoblotting and densitometric quantification of osteopontin (SPP1), thrombospondin 4 (THBS4), CD62P (SELP) and Emilin 1. Statistical significance of the relative signal intensity normalized to total protein (unmodified membranes, Supplementary Figure 5) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating the interquartile range (IQR), the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=7 per group). (G) Unsupervised hierarchical clustering of the differentially enriched proteins (p<0.05). (H) Reactome pathway enrichment analysis of proteins enriched (n=5) or uniquely quantified (n=18) in TAV. All Reactome pathways and annotations (Supplementary Table 9). (I) GO Cellular Component enrichment analysis of proteins enriched (n=98) in BAV. All GO Cellular Component pathways and annotations (Supplementary Table 10). (J) Orthogonal validation of differential abundance of “Ficolin-1 rich Granule” and “Tertiary Granule” associated proteins cathepsin D (CTSD) and CD58 as well as <t>classic</t> <t>neutrophil</t> degranulation markers neutrophil elastase (ELANE), myeloperoxidase <t>(MPO),</t> and Ficolin-1 (FCN1) by immunoblotting and densitometric quantification of relative signal intensities normalized to total protein (unmodified membranes, Supplementary Figure 6) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating IQR, the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=6 per group). (K) Functional Network of BAV-associated proteins. Network based on Reactome pathway enrichment among proteins significantly differentially enriched (n=98) or unique (n=93) in BAV. Protein-protein interaction network was produced by mapping the gene list onto STRING (confidence level >0.700) and k-means clustering partitioned the network into distinct functional modules.
Plasma Cyp2c19 Protein Levels, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+plasma/Human+Cytochrome+P450+2C19/pm42891844-69-0-22
Average 94 stars, based on 1 article reviews
plasma cyp2c19 protein levels - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Lee Biosolutions prostate cancer
(A) Mass spectrometry-based proteomics of LEVs from BAV (n=12) and TAV (n=8). (A) Venn diagram of quantified proteins and the proportion of proteins previously identified in LEVs from platelets, endothelial cells, neutrophils, erythrocytes, and lipoproteins. [*] indicates that some proteins were identified in multiple data sets. Proteome overlap analysis (Supplementary Table 4). (B) Gene Ontology (GO) Cellular Component enrichment analysis of all quantified LEV proteins. All Cellular Component pathways and annotations (Supplementary Table 5). (C) Plasma LEV principal component analysis with density plots. (D) Venn diagram of the proteins unique to TAV (n=18) or BAV (n=93) or shared between the groups (n=804). Full list of unique proteins (Supplementary Table 6). (D) Volcano plot of differentially enrichment analysis between BAV and TAV using a t-test. Proteins highlighted in red are enriched in TAV (n=5), proteins highlighted in blue and enriched in BAV (n=98, p<0.05, Supplementary Table 8). (F) Orthogonal validation of differentially enriched proteins by immunoblotting and densitometric quantification of osteopontin (SPP1), thrombospondin 4 (THBS4), CD62P (SELP) and Emilin 1. Statistical significance of the relative signal intensity normalized to total protein (unmodified membranes, Supplementary Figure 5) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating the interquartile range (IQR), the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=7 per group). (G) Unsupervised hierarchical clustering of the differentially enriched proteins (p<0.05). (H) Reactome pathway enrichment analysis of proteins enriched (n=5) or uniquely quantified (n=18) in TAV. All Reactome pathways and annotations (Supplementary Table 9). (I) GO Cellular Component enrichment analysis of proteins enriched (n=98) in BAV. All GO Cellular Component pathways and annotations (Supplementary Table 10). (J) Orthogonal validation of differential abundance of “Ficolin-1 rich Granule” and “Tertiary Granule” associated proteins cathepsin D (CTSD) and CD58 as well as <t>classic</t> <t>neutrophil</t> degranulation markers neutrophil elastase (ELANE), myeloperoxidase <t>(MPO),</t> and Ficolin-1 (FCN1) by immunoblotting and densitometric quantification of relative signal intensities normalized to total protein (unmodified membranes, Supplementary Figure 6) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating IQR, the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=6 per group). (K) Functional Network of BAV-associated proteins. Network based on Reactome pathway enrichment among proteins significantly differentially enriched (n=98) or unique (n=93) in BAV. Protein-protein interaction network was produced by mapping the gene list onto STRING (confidence level >0.700) and k-means clustering partitioned the network into distinct functional modules.
Prostate Cancer, supplied by Lee Biosolutions, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+plasma/Plasma+-+Human+Prostate+Cancer+Patient/pm42887692-87-13-20
Average 94 stars, based on 1 article reviews
prostate cancer - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Innovative Research Inc plasma spiked pbs
(A) Mass spectrometry-based proteomics of LEVs from BAV (n=12) and TAV (n=8). (A) Venn diagram of quantified proteins and the proportion of proteins previously identified in LEVs from platelets, endothelial cells, neutrophils, erythrocytes, and lipoproteins. [*] indicates that some proteins were identified in multiple data sets. Proteome overlap analysis (Supplementary Table 4). (B) Gene Ontology (GO) Cellular Component enrichment analysis of all quantified LEV proteins. All Cellular Component pathways and annotations (Supplementary Table 5). (C) Plasma LEV principal component analysis with density plots. (D) Venn diagram of the proteins unique to TAV (n=18) or BAV (n=93) or shared between the groups (n=804). Full list of unique proteins (Supplementary Table 6). (D) Volcano plot of differentially enrichment analysis between BAV and TAV using a t-test. Proteins highlighted in red are enriched in TAV (n=5), proteins highlighted in blue and enriched in BAV (n=98, p<0.05, Supplementary Table 8). (F) Orthogonal validation of differentially enriched proteins by immunoblotting and densitometric quantification of osteopontin (SPP1), thrombospondin 4 (THBS4), CD62P (SELP) and Emilin 1. Statistical significance of the relative signal intensity normalized to total protein (unmodified membranes, Supplementary Figure 5) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating the interquartile range (IQR), the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=7 per group). (G) Unsupervised hierarchical clustering of the differentially enriched proteins (p<0.05). (H) Reactome pathway enrichment analysis of proteins enriched (n=5) or uniquely quantified (n=18) in TAV. All Reactome pathways and annotations (Supplementary Table 9). (I) GO Cellular Component enrichment analysis of proteins enriched (n=98) in BAV. All GO Cellular Component pathways and annotations (Supplementary Table 10). (J) Orthogonal validation of differential abundance of “Ficolin-1 rich Granule” and “Tertiary Granule” associated proteins cathepsin D (CTSD) and CD58 as well as <t>classic</t> <t>neutrophil</t> degranulation markers neutrophil elastase (ELANE), myeloperoxidase <t>(MPO),</t> and Ficolin-1 (FCN1) by immunoblotting and densitometric quantification of relative signal intensities normalized to total protein (unmodified membranes, Supplementary Figure 6) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating IQR, the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=6 per group). (K) Functional Network of BAV-associated proteins. Network based on Reactome pathway enrichment among proteins significantly differentially enriched (n=98) or unique (n=93) in BAV. Protein-protein interaction network was produced by mapping the gene list onto STRING (confidence level >0.700) and k-means clustering partitioned the network into distinct functional modules.
Plasma Spiked Pbs, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+plasma/Pooled+Human+Plasma/pm42867017-285-0-17
Average 96 stars, based on 1 article reviews
plasma spiked pbs - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

93
Innovative Research Inc heat inactivated human blood type ab serum
(A) Mass spectrometry-based proteomics of LEVs from BAV (n=12) and TAV (n=8). (A) Venn diagram of quantified proteins and the proportion of proteins previously identified in LEVs from platelets, endothelial cells, neutrophils, erythrocytes, and lipoproteins. [*] indicates that some proteins were identified in multiple data sets. Proteome overlap analysis (Supplementary Table 4). (B) Gene Ontology (GO) Cellular Component enrichment analysis of all quantified LEV proteins. All Cellular Component pathways and annotations (Supplementary Table 5). (C) Plasma LEV principal component analysis with density plots. (D) Venn diagram of the proteins unique to TAV (n=18) or BAV (n=93) or shared between the groups (n=804). Full list of unique proteins (Supplementary Table 6). (D) Volcano plot of differentially enrichment analysis between BAV and TAV using a t-test. Proteins highlighted in red are enriched in TAV (n=5), proteins highlighted in blue and enriched in BAV (n=98, p<0.05, Supplementary Table 8). (F) Orthogonal validation of differentially enriched proteins by immunoblotting and densitometric quantification of osteopontin (SPP1), thrombospondin 4 (THBS4), CD62P (SELP) and Emilin 1. Statistical significance of the relative signal intensity normalized to total protein (unmodified membranes, Supplementary Figure 5) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating the interquartile range (IQR), the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=7 per group). (G) Unsupervised hierarchical clustering of the differentially enriched proteins (p<0.05). (H) Reactome pathway enrichment analysis of proteins enriched (n=5) or uniquely quantified (n=18) in TAV. All Reactome pathways and annotations (Supplementary Table 9). (I) GO Cellular Component enrichment analysis of proteins enriched (n=98) in BAV. All GO Cellular Component pathways and annotations (Supplementary Table 10). (J) Orthogonal validation of differential abundance of “Ficolin-1 rich Granule” and “Tertiary Granule” associated proteins cathepsin D (CTSD) and CD58 as well as <t>classic</t> <t>neutrophil</t> degranulation markers neutrophil elastase (ELANE), myeloperoxidase <t>(MPO),</t> and Ficolin-1 (FCN1) by immunoblotting and densitometric quantification of relative signal intensities normalized to total protein (unmodified membranes, Supplementary Figure 6) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating IQR, the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=6 per group). (K) Functional Network of BAV-associated proteins. Network based on Reactome pathway enrichment among proteins significantly differentially enriched (n=98) or unique (n=93) in BAV. Protein-protein interaction network was produced by mapping the gene list onto STRING (confidence level >0.700) and k-means clustering partitioned the network into distinct functional modules.
Heat Inactivated Human Blood Type Ab Serum, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+plasma/Pooled+Human+AB+Serum+Plasma+Derived+Heat+Inactivated/pm42836482-24-25-33
Average 93 stars, based on 1 article reviews
heat inactivated human blood type ab serum - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Monobind human plasma
(A) Mass spectrometry-based proteomics of LEVs from BAV (n=12) and TAV (n=8). (A) Venn diagram of quantified proteins and the proportion of proteins previously identified in LEVs from platelets, endothelial cells, neutrophils, erythrocytes, and lipoproteins. [*] indicates that some proteins were identified in multiple data sets. Proteome overlap analysis (Supplementary Table 4). (B) Gene Ontology (GO) Cellular Component enrichment analysis of all quantified LEV proteins. All Cellular Component pathways and annotations (Supplementary Table 5). (C) Plasma LEV principal component analysis with density plots. (D) Venn diagram of the proteins unique to TAV (n=18) or BAV (n=93) or shared between the groups (n=804). Full list of unique proteins (Supplementary Table 6). (D) Volcano plot of differentially enrichment analysis between BAV and TAV using a t-test. Proteins highlighted in red are enriched in TAV (n=5), proteins highlighted in blue and enriched in BAV (n=98, p<0.05, Supplementary Table 8). (F) Orthogonal validation of differentially enriched proteins by immunoblotting and densitometric quantification of osteopontin (SPP1), thrombospondin 4 (THBS4), CD62P (SELP) and Emilin 1. Statistical significance of the relative signal intensity normalized to total protein (unmodified membranes, Supplementary Figure 5) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating the interquartile range (IQR), the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=7 per group). (G) Unsupervised hierarchical clustering of the differentially enriched proteins (p<0.05). (H) Reactome pathway enrichment analysis of proteins enriched (n=5) or uniquely quantified (n=18) in TAV. All Reactome pathways and annotations (Supplementary Table 9). (I) GO Cellular Component enrichment analysis of proteins enriched (n=98) in BAV. All GO Cellular Component pathways and annotations (Supplementary Table 10). (J) Orthogonal validation of differential abundance of “Ficolin-1 rich Granule” and “Tertiary Granule” associated proteins cathepsin D (CTSD) and CD58 as well as <t>classic</t> <t>neutrophil</t> degranulation markers neutrophil elastase (ELANE), myeloperoxidase <t>(MPO),</t> and Ficolin-1 (FCN1) by immunoblotting and densitometric quantification of relative signal intensities normalized to total protein (unmodified membranes, Supplementary Figure 6) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating IQR, the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=6 per group). (K) Functional Network of BAV-associated proteins. Network based on Reactome pathway enrichment among proteins significantly differentially enriched (n=98) or unique (n=93) in BAV. Protein-protein interaction network was produced by mapping the gene list onto STRING (confidence level >0.700) and k-means clustering partitioned the network into distinct functional modules.
Human Plasma, supplied by Monobind, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+plasma/Human+Plasma+-+Recovered+Units/pm42731656-152-20-22
Average 94 stars, based on 1 article reviews
human plasma - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Lee Biosolutions charcoal
(A) Mass spectrometry-based proteomics of LEVs from BAV (n=12) and TAV (n=8). (A) Venn diagram of quantified proteins and the proportion of proteins previously identified in LEVs from platelets, endothelial cells, neutrophils, erythrocytes, and lipoproteins. [*] indicates that some proteins were identified in multiple data sets. Proteome overlap analysis (Supplementary Table 4). (B) Gene Ontology (GO) Cellular Component enrichment analysis of all quantified LEV proteins. All Cellular Component pathways and annotations (Supplementary Table 5). (C) Plasma LEV principal component analysis with density plots. (D) Venn diagram of the proteins unique to TAV (n=18) or BAV (n=93) or shared between the groups (n=804). Full list of unique proteins (Supplementary Table 6). (D) Volcano plot of differentially enrichment analysis between BAV and TAV using a t-test. Proteins highlighted in red are enriched in TAV (n=5), proteins highlighted in blue and enriched in BAV (n=98, p<0.05, Supplementary Table 8). (F) Orthogonal validation of differentially enriched proteins by immunoblotting and densitometric quantification of osteopontin (SPP1), thrombospondin 4 (THBS4), CD62P (SELP) and Emilin 1. Statistical significance of the relative signal intensity normalized to total protein (unmodified membranes, Supplementary Figure 5) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating the interquartile range (IQR), the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=7 per group). (G) Unsupervised hierarchical clustering of the differentially enriched proteins (p<0.05). (H) Reactome pathway enrichment analysis of proteins enriched (n=5) or uniquely quantified (n=18) in TAV. All Reactome pathways and annotations (Supplementary Table 9). (I) GO Cellular Component enrichment analysis of proteins enriched (n=98) in BAV. All GO Cellular Component pathways and annotations (Supplementary Table 10). (J) Orthogonal validation of differential abundance of “Ficolin-1 rich Granule” and “Tertiary Granule” associated proteins cathepsin D (CTSD) and CD58 as well as <t>classic</t> <t>neutrophil</t> degranulation markers neutrophil elastase (ELANE), myeloperoxidase <t>(MPO),</t> and Ficolin-1 (FCN1) by immunoblotting and densitometric quantification of relative signal intensities normalized to total protein (unmodified membranes, Supplementary Figure 6) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating IQR, the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=6 per group). (K) Functional Network of BAV-associated proteins. Network based on Reactome pathway enrichment among proteins significantly differentially enriched (n=98) or unique (n=93) in BAV. Protein-protein interaction network was produced by mapping the gene list onto STRING (confidence level >0.700) and k-means clustering partitioned the network into distinct functional modules.
Charcoal, supplied by Lee Biosolutions, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+plasma/Human+Plasma+-+Charcoal+Stripped+x+3/pm42604933-60-0-15
Average 94 stars, based on 1 article reviews
charcoal - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Lee Biosolutions human plasma
(A) Mass spectrometry-based proteomics of LEVs from BAV (n=12) and TAV (n=8). (A) Venn diagram of quantified proteins and the proportion of proteins previously identified in LEVs from platelets, endothelial cells, neutrophils, erythrocytes, and lipoproteins. [*] indicates that some proteins were identified in multiple data sets. Proteome overlap analysis (Supplementary Table 4). (B) Gene Ontology (GO) Cellular Component enrichment analysis of all quantified LEV proteins. All Cellular Component pathways and annotations (Supplementary Table 5). (C) Plasma LEV principal component analysis with density plots. (D) Venn diagram of the proteins unique to TAV (n=18) or BAV (n=93) or shared between the groups (n=804). Full list of unique proteins (Supplementary Table 6). (D) Volcano plot of differentially enrichment analysis between BAV and TAV using a t-test. Proteins highlighted in red are enriched in TAV (n=5), proteins highlighted in blue and enriched in BAV (n=98, p<0.05, Supplementary Table 8). (F) Orthogonal validation of differentially enriched proteins by immunoblotting and densitometric quantification of osteopontin (SPP1), thrombospondin 4 (THBS4), CD62P (SELP) and Emilin 1. Statistical significance of the relative signal intensity normalized to total protein (unmodified membranes, Supplementary Figure 5) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating the interquartile range (IQR), the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=7 per group). (G) Unsupervised hierarchical clustering of the differentially enriched proteins (p<0.05). (H) Reactome pathway enrichment analysis of proteins enriched (n=5) or uniquely quantified (n=18) in TAV. All Reactome pathways and annotations (Supplementary Table 9). (I) GO Cellular Component enrichment analysis of proteins enriched (n=98) in BAV. All GO Cellular Component pathways and annotations (Supplementary Table 10). (J) Orthogonal validation of differential abundance of “Ficolin-1 rich Granule” and “Tertiary Granule” associated proteins cathepsin D (CTSD) and CD58 as well as <t>classic</t> <t>neutrophil</t> degranulation markers neutrophil elastase (ELANE), myeloperoxidase <t>(MPO),</t> and Ficolin-1 (FCN1) by immunoblotting and densitometric quantification of relative signal intensities normalized to total protein (unmodified membranes, Supplementary Figure 6) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating IQR, the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=6 per group). (K) Functional Network of BAV-associated proteins. Network based on Reactome pathway enrichment among proteins significantly differentially enriched (n=98) or unique (n=93) in BAV. Protein-protein interaction network was produced by mapping the gene list onto STRING (confidence level >0.700) and k-means clustering partitioned the network into distinct functional modules.
Human Plasma, supplied by Lee Biosolutions, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+plasma/Human+Donor+Plasma+-+Hypertension/pmc13478627-81-1-15
Average 94 stars, based on 1 article reviews
human plasma - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


(A) Mass spectrometry-based proteomics of LEVs from BAV (n=12) and TAV (n=8). (A) Venn diagram of quantified proteins and the proportion of proteins previously identified in LEVs from platelets, endothelial cells, neutrophils, erythrocytes, and lipoproteins. [*] indicates that some proteins were identified in multiple data sets. Proteome overlap analysis (Supplementary Table 4). (B) Gene Ontology (GO) Cellular Component enrichment analysis of all quantified LEV proteins. All Cellular Component pathways and annotations (Supplementary Table 5). (C) Plasma LEV principal component analysis with density plots. (D) Venn diagram of the proteins unique to TAV (n=18) or BAV (n=93) or shared between the groups (n=804). Full list of unique proteins (Supplementary Table 6). (D) Volcano plot of differentially enrichment analysis between BAV and TAV using a t-test. Proteins highlighted in red are enriched in TAV (n=5), proteins highlighted in blue and enriched in BAV (n=98, p<0.05, Supplementary Table 8). (F) Orthogonal validation of differentially enriched proteins by immunoblotting and densitometric quantification of osteopontin (SPP1), thrombospondin 4 (THBS4), CD62P (SELP) and Emilin 1. Statistical significance of the relative signal intensity normalized to total protein (unmodified membranes, Supplementary Figure 5) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating the interquartile range (IQR), the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=7 per group). (G) Unsupervised hierarchical clustering of the differentially enriched proteins (p<0.05). (H) Reactome pathway enrichment analysis of proteins enriched (n=5) or uniquely quantified (n=18) in TAV. All Reactome pathways and annotations (Supplementary Table 9). (I) GO Cellular Component enrichment analysis of proteins enriched (n=98) in BAV. All GO Cellular Component pathways and annotations (Supplementary Table 10). (J) Orthogonal validation of differential abundance of “Ficolin-1 rich Granule” and “Tertiary Granule” associated proteins cathepsin D (CTSD) and CD58 as well as classic neutrophil degranulation markers neutrophil elastase (ELANE), myeloperoxidase (MPO), and Ficolin-1 (FCN1) by immunoblotting and densitometric quantification of relative signal intensities normalized to total protein (unmodified membranes, Supplementary Figure 6) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating IQR, the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=6 per group). (K) Functional Network of BAV-associated proteins. Network based on Reactome pathway enrichment among proteins significantly differentially enriched (n=98) or unique (n=93) in BAV. Protein-protein interaction network was produced by mapping the gene list onto STRING (confidence level >0.700) and k-means clustering partitioned the network into distinct functional modules.

Journal: bioRxiv

Article Title: Multiparametric Extracellular Vesicle Profiling Identifies a Distinct Circulating Signature of Bicuspid Aortic Valve Disease

doi: 10.64898/2026.11.03.763956

Figure Lengend Snippet: (A) Mass spectrometry-based proteomics of LEVs from BAV (n=12) and TAV (n=8). (A) Venn diagram of quantified proteins and the proportion of proteins previously identified in LEVs from platelets, endothelial cells, neutrophils, erythrocytes, and lipoproteins. [*] indicates that some proteins were identified in multiple data sets. Proteome overlap analysis (Supplementary Table 4). (B) Gene Ontology (GO) Cellular Component enrichment analysis of all quantified LEV proteins. All Cellular Component pathways and annotations (Supplementary Table 5). (C) Plasma LEV principal component analysis with density plots. (D) Venn diagram of the proteins unique to TAV (n=18) or BAV (n=93) or shared between the groups (n=804). Full list of unique proteins (Supplementary Table 6). (D) Volcano plot of differentially enrichment analysis between BAV and TAV using a t-test. Proteins highlighted in red are enriched in TAV (n=5), proteins highlighted in blue and enriched in BAV (n=98, p<0.05, Supplementary Table 8). (F) Orthogonal validation of differentially enriched proteins by immunoblotting and densitometric quantification of osteopontin (SPP1), thrombospondin 4 (THBS4), CD62P (SELP) and Emilin 1. Statistical significance of the relative signal intensity normalized to total protein (unmodified membranes, Supplementary Figure 5) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating the interquartile range (IQR), the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=7 per group). (G) Unsupervised hierarchical clustering of the differentially enriched proteins (p<0.05). (H) Reactome pathway enrichment analysis of proteins enriched (n=5) or uniquely quantified (n=18) in TAV. All Reactome pathways and annotations (Supplementary Table 9). (I) GO Cellular Component enrichment analysis of proteins enriched (n=98) in BAV. All GO Cellular Component pathways and annotations (Supplementary Table 10). (J) Orthogonal validation of differential abundance of “Ficolin-1 rich Granule” and “Tertiary Granule” associated proteins cathepsin D (CTSD) and CD58 as well as classic neutrophil degranulation markers neutrophil elastase (ELANE), myeloperoxidase (MPO), and Ficolin-1 (FCN1) by immunoblotting and densitometric quantification of relative signal intensities normalized to total protein (unmodified membranes, Supplementary Figure 6) was determined using a two-sided Wilcoxon rank sum test. Data are presented as box-and-whisker plots, with the box indicating IQR, the center line representing the median, and whiskers extending to 1.5×IQR. Individual points represent individual donors (n=6 per group). (K) Functional Network of BAV-associated proteins. Network based on Reactome pathway enrichment among proteins significantly differentially enriched (n=98) or unique (n=93) in BAV. Protein-protein interaction network was produced by mapping the gene list onto STRING (confidence level >0.700) and k-means clustering partitioned the network into distinct functional modules.

Article Snippet: ELISA kits to quantify plasma levels of MPO (DMYE00B, Quantikine) and neutrophil elastase (DY9167-05, Duoset) were purchased from R&D Systems.

Techniques: Mass Spectrometry, Proteomic Assay, Analysis, Clinical Proteomics, Biomarker Discovery, Western Blot, Whisker Assay, Functional Assay, Produced